This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message:
Sent on Tuesday, 2009 Aug 25Search kinetoplastids OR kinetoplastid OR Kinetoplastida OR "trypanosoma brucei" OR leishmania OR brucei OR leishmaniasis OR "African trypanosomiasis"
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.
| PubMed Results |
-
Heterologous expression of L. major proteins in S. cerevisiae: a test of solubility, purity, and gene recoding.
Center for Pediatric Biomedical Research, University of Rochester Medical School, Rochester, NY, 14642, USA.
High level expression of many eukaryotic proteins for structural analysis is likely to require a eukaryotic host since many proteins are either insoluble or lack essential post-translational modifications when expressed in E. coli. The well-studied eukaryote Saccharomyces cerevisiae possesses several attributes of a good expression host: it is simple and inexpensive to culture, has proven genetic tractability, and has excellent recombinant DNA tools. We demonstrate here that this yeast exhibits three additional characteristics that are desirable in a eukaryotic expression host. First, expression in yeast significantly improves the solubility of proteins that are expressed but insoluble in E. coli. The expression and solubility of 83 Leishmania major ORFs were compared in S. cerevisiae and in E. coli, with the result that 42 of the 64 ORFs with good expression and poor solubility in E. coli are highly soluble in S. cerevisiae. Second, the yield and purity of heterologous proteins expressed in yeast is sufficient for structural analysis, as demonstrated with both small scale purifications of 21 highly expressed proteins and large scale purifications of 2 proteins, which yield highly homogeneous preparations. Third, protein expression can be improved by altering codon usage, based on the observation that a codon-optimized construct of one ORF yields three-fold more protein. Thus, these results provide direct verification that high level expression and purification of heterologous proteins in S. cerevisiae is feasible and likely to improve expression of proteins whose solubility in E. coli is poor.
PMID: 19701618 [PubMed - as supplied by publisher]
-
Related articles
- How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli.
BMC Genomics. 2005 Apr 2; 6(1):49. Epub 2005 Apr 2.
[BMC Genomics. 2005]
- Functional expression of mammalian adenosine cyclic monophosphate-dependent protein kinase in Saccharomyces cerevisiae.
Methods Enzymol. 1991; 200:605-27.
[Methods Enzymol. 1991]
- The transcriptional response of Escherichia coli to recombinant protein insolubility.
J Struct Funct Genomics. 2007 Mar; 8(1):27-35. Epub 2007 Nov 9.
[J Struct Funct Genomics. 2007]
- ReviewOptimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
Biotechnol Annu Rev. 2007; 13:27-42.
[Biotechnol Annu Rev. 2007]
- ReviewExpression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.
J Mol Recognit. 2005 Mar-Apr; 18(2):119-38.
[J Mol Recognit. 2005]
- » See reviews... | » See all...
- How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli.
- 2: J Am Acad Dermatol. 2009 Sep;61(3):441-50.
-
More experiences with the Tzanck smear test: cytologic findings in cutaneous granulomatous disorders.
Department of Dermatology, Başkent University Faculty of Medicine, Adana, Turkey.
BACKGROUND: Granulomatous dermatitis is a distinctive histopathologic cutaneous reaction pattern against various infectious and noninfectious agents. Cytologically, granulomatous dermatitis shows granulomas and multinucleated giant cells. Various etiologic agents of granulomatous diseases can also be identified. OBJECTIVE: We aimed to investigate Tzanck smear findings in granulomatous skin diseases. METHODS: Patients who had granulomas and/or multinucleated giant cells of Langhans, foreign body- and/or Touton type in Tzanck smear tests were included in the study. In these patients, Tzanck preparations were then further evaluated for additional cytologic findings. Samples stained with May-Grünwald-Giemsa stain were evaluated by the same dermatologist throughout the study. In some patients, methylene blue, Gram and/or Erlich-Ziehl-Nielsen stains were also performed. In all of the study cases, the final diagnosis was established after the evaluation of clinical and laboratory findings (including, when appropriate, potassium hydroxide examination; bacterial, leishmanial, and fungal cultures; histopathology; tuberculosis and leishmania polymerase chain reaction). We also calculated the sensitivity and specificity of the Leishman-Donovan body for cutaneous leishmaniasis. RESULTS: Over a 2-year period, 94 of 950 patients (9.9%) in whom Tzanck smear tests were performed had cytologic findings consistent with a granulomatous reaction. In 74 (78.7%) and 20 (21.3%) patients, the granulomatous reaction was due to infectious and noninfectious causes, respectively. Infectious causes included cutaneous leishmaniasis in 65 patients (87.8%), candidal granuloma in two patients, botyromycosis in two patients, and aspergillosis, blastomycosis, mucormycosis, leprosy, and cutaneous tuberculosis in one patient each. In 58 of 74 patients (78.4%) with infectious granulomatous dermatitis, the causes of the granulomas were identified. Noninfectious granulomatous reactions were due to granuloma annulare in 7 patients, sarcoidosis in 5 patients, a foreign body in 4 patients, necrobiosis lipoidica in 2 patients, and juvenile xanthogranuloma in 2 patients. In 17 of 20 patients (85%) with noninfectious granulomatous reactions, the cytologic findings were characteristic of the final diagnoses. The sensitivity and specificity of Leishman-Donovan bodies for cutaneous leishmaniasis were 76.9% and 100%, respectively. LIMITATIONS: All of the samples were evaluated by the same dermatologist throughout the study; therefore no comment could be made regarding the reliability of the Tzanck smear test. In addition, the sensitivity and specificity of Tzanck smear test findings for diseases other than cutaneous leishmaniasis could not be calculated because of an insufficient number of patients. CONCLUSION: The Tzanck smear test may be a useful diagnostic tool for certain granulomatous skin diseases.
PMID: 19700014 [PubMed - in process]
-
Related articles
- The value of Tzanck smear test in diagnosis of erosive, vesicular, bullous, and pustular skin lesions.
J Am Acad Dermatol. 2008 Dec; 59(6):958-64. Epub 2008 Oct 16.
[J Am Acad Dermatol. 2008]
- [Granulomatous diseases and pathogenic microorganism]
Kekkaku. 2008 Feb; 83(2):115-30.
[Kekkaku. 2008]
- Unusual histopathological features of cutaneous leishmaniasis identified by polymerase chain reaction specific for Leishmania on paraffin-embedded skin biopsies.
Br J Dermatol. 2006 Oct; 155(4):815-9.
[Br J Dermatol. 2006]
- ReviewDiagnosis and treatment of pustular disorders in the neonate.
Pediatr Dermatol. 1997 Mar-Apr; 14(2):131-43.
[Pediatr Dermatol. 1997]
- ReviewCutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature.
J Am Acad Dermatol. 1997 Jun; 36(6 Pt 1):899-907.
[J Am Acad Dermatol. 1997]
- » See reviews... | » See all...
Patient Drug Information
- Potassium (Glu-K®, K+ 10®, K+ 8®, ...)
Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney dis...
- The value of Tzanck smear test in diagnosis of erosive, vesicular, bullous, and pustular skin lesions.
-
Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum.
Department of Chemistry, Georgia State University, Atlanta, GA 30303-3083, USA.
A series of azaterphenyl diamidines has been synthesized and evaluated for in vitro antiprotozoal activity against both Trypanosoma brucei rhodesiense (T. b. r.) and Plasmodium falciparum (P. f.) and in vivo efficacy in the STIB900 acute mouse model for T. b. r. Six of the 13 compounds showed IC(50) values less than 7nM against T. b. r. Twelve of those exhibited IC(50) values less than 6nM against P. f. and six of those showed IC(50) values 0.6nM, which are more than 25-fold as potent as furamidine. Moreover, two of them showed more than 40-fold selectivity for P. f. versus T. b. r. Three compounds 15b, 19d and 19e exhibited in vivo efficacy against T. b. r. much superior to furamidine, and equivalent to or better than azafuramidine. The antiparasitic activity of these diamidines depends on the ring nitrogen atom(s) location relative to the amidine groups and generally correlates with DNA binding affinity.
PMID: 19699098 [PubMed - as supplied by publisher]
-
Related articles
- Dicationic biphenyl benzimidazole derivatives as antiprotozoal agents.
Bioorg Med Chem. 2004 Oct 15; 12(20):5405-13.
[Bioorg Med Chem. 2004]
- Synthesis and antiprotozoal activity of aza-analogues of furamidine.
J Med Chem. 2003 Oct 23; 46(22):4761-9.
[J Med Chem. 2003]
- Synthesis and Antiprotozoal Activity of Pyridyl Analogues of Pentamidine.
J Med Chem. 2009 Jul 17; . Epub 2009 Jul 17.
[J Med Chem. 2009]
- ReviewDiamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Curr Opin Investig Drugs. 2006 Feb; 7(2):147-57.
[Curr Opin Investig Drugs. 2006]
- ReviewDevelopment of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Int J Mol Med. 2008 Oct; 22(4):411-9.
[Int J Mol Med. 2008]
- » See reviews... | » See all...
- Dicationic biphenyl benzimidazole derivatives as antiprotozoal agents.
-
Challenges and perspectives in vaccination against leishmaniasis.
Centro de Pesquisas Gonçalo Muniz-FIOCRUZ, Salvador, BA, Brazil.
The leishmaniases are a group of diseases caused by protozoa of the genus Leishmania which affect millions of people worldwide. The leishmaniases are transmitted to the vertebrate hosts by phlebotomine sand flies. In this review, we focus on areas poorly addressed in the ongoing efforts to develop a vaccine against Leishmania, namely: vaccination with antigens present in sand fly saliva, vaccines based on intracellular Leishmania antigens and use of recombinant BCG as a vehicle for vaccination. Additionally, we address the differences between L. major and L. braziliensis and the impact that it may have on strategies for immunoprophylaxis.
PMID: 19698801 [PubMed - as supplied by publisher]
-
Related articles
- ReviewVaccines in leishmaniasis: advances in the last five years.
Expert Rev Vaccines. 2003 Oct; 2(5):705-17.
[Expert Rev Vaccines. 2003]
- ReviewRecombinant DNA-derived leishmania proteins: from the laboratory to the field.
Lancet Infect Dis. 2005 Feb; 5(2):107-14.
[Lancet Infect Dis. 2005]
- ReviewRole of sand fly saliva in human and experimental leishmaniasis: current insights.
Scand J Immunol. 2007 Aug-Sep; 66(2-3):122-7.
[Scand J Immunol. 2007]
- ReviewSand fly saliva: effects on host immune response and Leishmania transmission.
Folia Parasitol (Praha). 2006 Sep; 53(3):161-71.
[Folia Parasitol (Praha). 2006]
- Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Clin Vaccine Immunol. 2007 Sep; 14(9):1173-81. Epub 2007 Jul 11.
[Clin Vaccine Immunol. 2007]
- » See reviews... | » See all...
Patient Drug Information
- Bacillus Calmette-Guerin (BCG) Vaccine (TheraCys® BCG, TICE® BCG)
BCG vaccine provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB. It is also used to treat bladder tumors or bladder cancer.
- ReviewVaccines in leishmaniasis: advances in the last five years.
-
Biochemical characterization of the initial steps of the Kennedy pathway in Trypanosoma brucei: the ethanolamine and choline kinases.
PMID: 19698088 [PubMed - in process]
-
Related articles
- Biochemical characterization of the initial steps of the Kennedy pathway in Trypanosoma brucei: the ethanolamine and choline kinases.
Biochem J. 2008 Oct 1; 415(1):135-44.
[Biochem J. 2008]
- The ethanolamine branch of the Kennedy pathway is essential in the bloodstream form of Trypanosoma brucei.
Mol Microbiol. 2009 Jun 23; . Epub 2009 Jun 23.
[Mol Microbiol. 2009]
- Phosphatidylethanolamine in Trypanosoma brucei is organized in two separate pools and is synthesized exclusively by the Kennedy pathway.
J Biol Chem. 2008 Aug 29; 283(35):23636-44. Epub 2008 Jun 28.
[J Biol Chem. 2008]
- ReviewCholine kinase from yeast.
Biochim Biophys Acta. 1997 Sep 4; 1348(1-2):63-9.
[Biochim Biophys Acta. 1997]
- ReviewWill the real Trypanosoma brucei rhodesiense please step forward?
Trends Parasitol. 2002 Nov; 18(11):486-90.
[Trends Parasitol. 2002]
- » See reviews... | » See all...
- Biochemical characterization of the initial steps of the Kennedy pathway in Trypanosoma brucei: the ethanolamine and choline kinases.
- 6: Molecules. 2009 Jun 22;14(6):2256-72.
-
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, University of Navarra, C/Irunlarrea s/n, 31008 Pamplona, Spain.
Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1,4-di-N-oxide derivatives have been prepared and tested against M. tuberculosis and T. cruzi. Carboxylic acid quinoxaline 1,4-di-N-oxides (CAQDOs) 5 and 17 showed MIC values on the same order as the reference antituberculosis drug, rifampicin. Meanwhile, CAQDOs 12 and 22 presented IC(50) values in the same order as the anti-chagasic drug, nifurtimox.
PMID: 19553897 [PubMed - indexed for MEDLINE]
-
Related articles
- In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
J Antimicrob Chemother. 2008 Sep; 62(3):547-54. Epub 2008 May 23.
[J Antimicrob Chemother. 2008]
- Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
Pharmazie. 1999 Jan; 54(1):24-5.
[Pharmazie. 1999]
- Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
Antimicrob Agents Chemother. 2008 Sep; 52(9):3321-6. Epub 2008 Jul 14.
[Antimicrob Agents Chemother. 2008]
- Review[Development of antituberculous drugs: current status and future prospects]
Kekkaku. 2006 Dec; 81(12):753-74.
[Kekkaku. 2006]
- ReviewOverview of anti-tuberculosis (TB) drugs and their resistance mechanisms.
Mini Rev Med Chem. 2007 Nov; 7(11):1177-85.
[Mini Rev Med Chem. 2007]
- » See reviews... | » See all...
Patient Drug Information
- Rifampin (Rifadin®, Rimactane®, Rifamate® as a combination product containing Rifampin and Isoniazid, ...)
Rifampin eliminates bacteria that cause tuberculosis (TB). It is generally used with other drugs to treat tuberculosis or to eliminate Neisseria meningitidis (a bacteria) and to prevent you from giving these infections t...
- In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
No comments:
Post a Comment